Intended Use

TrueFit/TrueFlex Bolus is indicated for and intended to be placed on the patient’s skin as an accessory to attenuate and/or compensate the external beam (photon or electron) radiation during the treatment of various types of cancer. The device is for a single patient’s use only and can be reused throughout the entirety of the treatment course. The device is designed by the radiation therapy professional using patient imaging data as input and must be verified and approved by the trained radiation therapy professional prior to use. The device is restricted to sale by or on the order of a physician and is by prescription only.

Technology

TrueFit/TrueFlex Bolus devices are 3D printed radiation therapy accessories designed using patient imaging data from treatment planning systems. TrueFit Bolus uses multi-jet fusion 3D printing with polyamide or polyurethane materials, while TrueFlex Bolus is manufactured using silicone by filling a 3D printed mold. These materials provide customized fit and radiological properties to accurately deliver radiation doses.

Performance

Verification and Validation testing using worst-case geometrical samples and real patient devices showed acceptable spatial fidelity and radiological properties, ensuring precise fit and safe, effective radiation delivery. Performance testing confirmed substantial equivalence to the legally marketed predicate device.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    9/27/2024

    26 days
  • 2

    FDA Approval

    10/23/2024

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.